125 related articles for article (PubMed ID: 22310641)
1. Vitamin D 25-hydroxylase - Four decades of searching, are we there yet?
Zhu J; DeLuca HF
Arch Biochem Biophys; 2012 Jul; 523(1):30-6. PubMed ID: 22310641
[TBL] [Abstract][Full Text] [Related]
2. Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1: enzymes and catalysis.
Hayashi K; Yasuda K; Sugimoto H; Ikushiro S; Kamakura M; Kittaka A; Horst RL; Chen TC; Ohta M; Shiro Y; Sakaki T
FEBS J; 2010 Oct; 277(19):3999-4009. PubMed ID: 20731719
[TBL] [Abstract][Full Text] [Related]
3. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
Chen TC; Sakaki T; Yamamoto K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of vitamin D(3) by human CYP27A1.
Sawada N; Sakaki T; Ohta M; Inouye K
Biochem Biophys Res Commun; 2000 Jul; 273(3):977-84. PubMed ID: 10891358
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxylation of vitamin D3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1.
Hosseinpour F; Ibranovic I; Tang W; Wikvall K
Biochem Biophys Res Commun; 2003 Apr; 303(3):877-83. PubMed ID: 12670492
[TBL] [Abstract][Full Text] [Related]
6. Enzymes involved in the activation and inactivation of vitamin D.
Prosser DE; Jones G
Trends Biochem Sci; 2004 Dec; 29(12):664-73. PubMed ID: 15544953
[TBL] [Abstract][Full Text] [Related]
7. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1.
Sawada N; Sakaki T; Yoneda S; Kusudo T; Shinkyo R; Ohta M; Inouye K
Biochem Biophys Res Commun; 2004 Jul; 320(1):156-64. PubMed ID: 15207715
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of a highly active vitamin D hydroxylase from Streptomyces griseolus CYP105A1.
Hayashi K; Sugimoto H; Shinkyo R; Yamada M; Ikeda S; Ikushiro S; Kamakura M; Shiro Y; Sakaki T
Biochemistry; 2008 Nov; 47(46):11964-72. PubMed ID: 18937506
[TBL] [Abstract][Full Text] [Related]
9. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites.
Kamao M; Tatematsu S; Sawada N; Sakaki T; Hatakeyama S; Kubodera N; Okano T
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):39-42. PubMed ID: 15225744
[TBL] [Abstract][Full Text] [Related]
10. Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites.
Ellfolk M; Norlin M; Wikvall K
Biochem Biophys Res Commun; 2006 Jun; 345(2):568-72. PubMed ID: 16690021
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic activation in vitamin D signaling - Past, present and future.
Norlin M; Wikvall K
Arch Biochem Biophys; 2023 Jul; 742():109639. PubMed ID: 37196753
[TBL] [Abstract][Full Text] [Related]
12. Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases.
Aiba I; Yamasaki T; Shinki T; Izumi S; Yamamoto K; Yamada S; Terato H; Ide H; Ohyama Y
Steroids; 2006 Oct; 71(10):849-56. PubMed ID: 16842832
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biology of cytochrome P450 in kidney].
Noshiro M; Ohyama Y
Nihon Rinsho; 1992 Dec; 50(12):3079-85. PubMed ID: 1337122
[TBL] [Abstract][Full Text] [Related]
14. The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase).
Hosseinpour F; Hidestrand M; Ingelman-Sundberg M; Wikvall K
Biochem Biophys Res Commun; 2001 Nov; 288(4):1059-63. PubMed ID: 11689019
[TBL] [Abstract][Full Text] [Related]
15. Role of a mutated residue at the entrance of the substrate access channel in cytochrome p450 engineered for vitamin D(3) hydroxylation activity.
Fukunishi H; Yagi H; Kamijo K; Shimada J
Biochemistry; 2011 Oct; 50(39):8302-10. PubMed ID: 21877691
[TBL] [Abstract][Full Text] [Related]
16. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
de Visser SP; Shaik S
J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
[TBL] [Abstract][Full Text] [Related]
17. Chronic contamination with 137Cesium affects Vitamin D3 metabolism in rats.
Tissandie E; Guéguen Y; Lobaccaro JM; Aigueperse J; Gourmelon P; Paquet F; Souidi M
Toxicology; 2006 Aug; 225(1):75-80. PubMed ID: 16806633
[TBL] [Abstract][Full Text] [Related]
18. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response.
Adams JS; Chen H; Chun R; Ren S; Wu S; Gacad M; Nguyen L; Ride J; Liu P; Modlin R; Hewison M
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V20-4. PubMed ID: 18290716
[TBL] [Abstract][Full Text] [Related]
19. Bioconversion of vitamin D to its active form by bacterial or mammalian cytochrome P450.
Sakaki T; Sugimoto H; Hayashi K; Yasuda K; Munetsuna E; Kamakura M; Ikushiro S; Shiro Y
Biochim Biophys Acta; 2011 Jan; 1814(1):249-56. PubMed ID: 20654743
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer.
Maksymchuk OV; Kashuba VI
Pharmacol Rep; 2020 Oct; 72(5):1161-1172. PubMed ID: 32681429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
